Related Experiment Video
Updated: Jun 10, 2026
07:21
Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
Multiple non-metastatic gastrointestinal stromal tumors. Differential features
M Díaz-Delgado1, A Hernández-Amate, M Sánchez-León
1Department of Pathology, Hospital de Mérida, Mérida, Badajoz, Spain.
Revista Espanola De Enfermedades Digestivas
|July 31, 2010
Summary
Multiple gastrointestinal stromal tumors (GISTs) can arise spontaneously, from familial syndromes, or associated syndromes. Distinguishing these from metastatic GISTs is crucial for appropriate clinical management.
Area of Science:
- Gastrointestinal Oncology
- Molecular Pathology
- Genetics of Neoplasia
Background:
- Gastrointestinal stromal tumors (GISTs) are KIT (CD117)-positive mesenchymal neoplasms of the digestive tract.
- GISTs typically arise from mutations in the KIT or PDGFRA genes.
- While often solitary, GISTs can present as multiple lesions.
Purpose of the Study:
- To review the clinicopathological features of multiple, non-metastatic GISTs.
- To differentiate various etiologies of multiple GISTs.
- To inform clinical awareness of distinct GIST variants.
Main Methods:
- Comprehensive literature review utilizing Medline database.
- Inclusion of authors' personal clinical experience.
- Analysis of morphological, immunohistochemical, and molecular data.
Main Results:
- Multiple GISTs identified in three primary contexts: spontaneous occurrence, familial GIST syndrome, and specific associated syndromes (Carney triad, Carney-Stratakis, NF1).
- Multiple GISTs outside these contexts are presumed metastatic and indicative of advanced disease.
- Distinct clinical presentations and genetic underpinnings exist for each category.
Conclusions:
- Recognition of multiple GIST variants is essential for accurate diagnosis and treatment planning.
- Familial and syndrome-associated multiple GISTs have different prognostic and therapeutic implications compared to metastatic disease.
- Clinicians must differentiate non-metastatic multiple GISTs from advanced-stage disease.